Stock DRW3 DRÄGERWERK AG & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Drägerwerk AG & Co. KGaA

Equities

DRW3

DE0005550636

Market Closed - Xetra
Other stock markets
 09:05:11 29/04/2024 pm IST 		Pre-market 11:40:17 am
50.6 EUR +3.58% Intraday chart for Drägerwerk AG & Co. KGaA 50.6 0.00%
29/04 DRAEGERWERK : Hauck & Aufhauser reiterates its Buy rating ZD
25/04 Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15 DP

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company's attractive earnings multiples are brought to light by a P/E ratio at 10.57 for the current year.
  • The company shows low valuation levels, with an enterprise value at 0.3 times its sales.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company does not generate enough profits, which is an alarming weak point.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
DRÄGERWERK AG & CO. KGAA Stock Drägerwerk AG & Co. KGaA
-2.32% 934M
B+
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.69% 220B
B
DANAHER CORPORATION Stock Danaher Corporation
+6.69% 183B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+10.90% 133B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+25.41% 107B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.27% 63.05B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.72% 51.74B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 50.47B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.40% 40.91B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+15.03% 40.59B -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DRW3 Stock
  4. Ratings Drägerwerk AG & Co. KGaA